Signaling pathways that control cell proliferation

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 3, 2013, Pages

  Duronio, Robert J ^a,b   Xiong, Yue ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; PROTEASOME; RETINOBLASTOMA PROTEIN; UBIQUITIN;

ANIMAL; BIOLOGICAL MODEL; CELL CYCLE; CELL PROLIFERATION; DRUG ANTAGONISM; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84874690598     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a008904     Document Type: Article

References (112)

1. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. 2008. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 22: 2496-2506.
2. Akiyama T, Ohuchi T, Sumida S, Matsumoto K, Toyoshima K. 1992. Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci 89: 7900-7904.
3. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270: 23589-23597.
4. Bates S, Peters G. 1995. Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol 6: 73-82.
5. Baugh LR, Sternberg PW. 2006. DAF-16/FOXO regulates transcription of cki-1/Cip/Kip and repression of lin-4 during C. elegans L1 arrest. Curr Biol 16: 780-785.
6. WAF1 to promote DNA repair. Cell 114: 599-610.
7. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. 2003. Cdk2 knock-out mice are viable. Curr Biol 13: 1775-1785.
8. Cip1 in S phase. J Biol Chem 278: 25752-25757.
9. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beek-man C, Theilgaard-Monch K, Minucci S, Porse BT, Marine JC, et al. 2007. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21: 525-530.
10. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
11. Buttitta LA, Katzaroff AJ, Perez CL, de la Cruz A, Edgar BA. 2007. A double-assurance mechanism controls cell cycle exit upon terminal differentiation in Drosophila. Dev Cell 12: 631-643.
12. Cao X, Pfaff SL, Gage FH. 2008. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 22: 3320-3334.
13. Clayton JE, van den Heuvel SJ, Saito RM. 2008. Transcriptional control of cell-cycle quiescence during C. elegans development. Dev Biol 313: 603-613.
14. 2 mitotic kinase. Cell 83: 1001-1009.
15. 1 /S transcription in yeast. Cell 117: 899-913.
16. Deb DK, Tanaka-Matakatsu M, Jones L, Richardson HE, Du W. 2008. Wingless signaling directly regulates cyclin E expression in proliferat-ing embryonic PNS precursor cells. Mech Dev 125: 857-864.
17. de Bruin RA, McDonald WH, Kalashnikova TI, Yates J 3rd, Wittenberg C. 2004. Cln3 activates G1 -specific transcription via phosphorylation of the SBF bound repressor Whi5. Cell 117: 887-898.
18. CIP1/WAF1 undergo normal development, but are defective in G 1 checkpoint control. Cell 82: 675-684.
19. de Nooij JC, Letendre MA, Hariharan IK. 1996. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87: 1237-1247.
20. Diehl JA, Cheng M, Roussel M, Sherr CJ. 1998. Glycogen synthase kinase-- 3b regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511.
21. Dulic V, Lees E, Reed SI. 1992. Association of human cyclin E with a periodic G 1 -S phase protein kinase. Science 257: 1958-1961.
22. Duronio RJ, O'Farrell PH. 1995. Developmental control of the G 1 to S transition in Drosophila: Cyclin E is a limiting downstream target of E2F. Genes Dev 9: 1456-1468.
23. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262.
24. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Lin DM, Mercer WE, Kinzler KWV, Vogelstein B. 1993. WAF1, a potential me-diator of p53 tumor suppression. Cell 75: 817-825.
25. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497.
26. Fay DS, Han M. 2000. Mutations in cye-1, a Caenorhabditis elegans cyclin E homolog, reveal coordination between cell-cycle control and vulval development. Development 127: 4049-4060.
27. Feldman RMR, Correll CC, Kaplan KB, Deshaies RJ. 1997. A complex of Cdc4p, Skp1p, and Cdc53p/Cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91: 221-230.
28. Ferrell JE Jr, Pomerening JR, Kim SY, Trunnell NB, Xiong W, Huang CY, Machleder EM. 2009. Simple, realistic models of complex biological processes: Positive feedback and bistability in a cell fate switch and a cell cycle oscillator. FEBS Lett 583: 3999-4005.
29. Firth LC, Baker NE. 2005. Extracellular signals responsible for spatially regulated proliferation in the differentiating Drosophila eye. Dev Cell 8: 541-551.
30. P1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12: 2899-2911.
31. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1180.
32. Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, Sicinski P. 1999. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97: 767-777.
33. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. 2003. Cyclin E ablation in the mouse. Cell 114: 431-443.
34. Hariharan I. 2013. Signaling pathways that regulate cell division. Cold Spring Harb Perspect Biol (to be published). Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-de-pendent kinases. Cell 75: 805-816.
35. Harvey KF, Hariharan IK. 2012. The Hippo pathway. Cold Spring Harb Perspect Biol 4: a011288. Havens CG, Walter JC. 2011. Mechanism of CRL4(Cdt2), a PCNA-de-pendent E3 ubiquitin ligase. Genes Dev 25: 1568-1582.
36. Hemmings BA, Restuccia DF. 2012. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 4: a011189.
37. Herrera RE, Sah VP, Williams BO, Makela TP, Weinberg RA, Jacks T. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol 16: 2402-2407.
38. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
39. Hong Y, Roy R, Ambros V. 1998. Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progres-sion in Caenorhabditis elegans. Development 125: 3585-3597.
40. Huang J, Wu S, Barrera J, Matthews K, Pan D. 2005. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by in-activating Yorkie, the Drosophila homolog of YAP. Cell 122: 421-434.
41. Hwang HC, Clurman BE. 2005. Cyclin E in normal and neoplastic cell cycles. Oncogene 24: 2776-2786.
42. Hwang CY, Lee C, Kwon KS. 2009. Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21 Cip1. Mol Cell Biol 29: 3379-3389.
43. Ingham PW. 2012. Hedgehog signaling. Cold Spring Harb Perspect Biol 4: a011221.
44. Inze D. 2005. Green light for the cell cycle. EMBO J 24: 657-662.
45. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell prolif-eration and senescence through the ink4a locus. Nature 397: 164-168.
46. Jones L, Richardson H, Saint R. 2000. Tissue-specific regulation of cyclin E transcription during Drosophila melanogaster embryogenesis. Devel-opment 127: 4619-4630.
47. Kip1 at G1 phase. Nat Cell Biol 6: 1229-1235.
48. Kanie T, Onoyama I, Matsumoto A, Yamada M, Nakatsumi H, Tateishi Y, Yamamura S, Tsunematsu R, Matsumoto M, Nakayama KI. 2012. Genetic reevaluation of the role of F-box proteins in cyclin D1 degra-dation. Mol Cell Biol 32: 590-605.
49. Kato J-Y, Matsushime H, Hiebert SW, Ewen M, Sherr CJ. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342.
50. 2 proteolysis regulates osteoblast cell differentiation. EMBO Rep 9: 878-884.
51. Kim Y, Starostina NG, Kipreos ET. 2008b. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev 22: 2507-2519.
52. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, et al. 1996. The consen-sus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15: 7060- 7069.
53. Klein EA, Assoian RK. 2008. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 121: 3853-3857.
54. Knoblich JA, Sauer K, Jones L, Richardson H, Saint R, Lehner CF. 1994. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell prolifera-tion. Cell 77: 107-120.
55. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishi-moto T, Morgan DO, Franza BR, Roberts JM. 1992. Formation and activation of a cyclin E-cdk2 complex during the G 1 phase of the human cell cycle. Science 257: 1689-1694.
56. Kominami K-I, Toda T. 1997. Fission yeast WD-repeat protein Pop1 regulates genome ploidy through ubiquitin-proteasome-mediated degradation of the CDK inhibitor Rum1 and the S-phase initiator Cdc18. Genes Dev 11: 1548-1560.
57. Kopan R. 2012. Notch signaling. Cold Spring Harb Perspect Biol 4: a011213.
58. Korzelius J, Nitesh I, Ruijtenberg S, Prinsen MB, Portegijs V, Middelkoop TC, Groot Koerkamp MJ, Holstege FC, Boxem M, van den Heuvel S. 2011. Caenorhabditis elegans cyclin D/CDK4 and cyclin E/CDK2 in-duce distinct cell cycle re-entry programs in differentiated muscle cells. PLoS Genet 7: e1002362.
59. a tumor suppressor gene. Genes Dev 21: 49-54.
60. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, et al. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118: 477-491.
61. Lane ME, Sauer K, Wallace K, Jan YN, Lehner CF, Vaessin H. 1996. Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell 87: 1225-1235.
62. Lew D, Dulic V, Reed SI. 1991. Isolation of three novel human cyclins by rescue of G 1 cyclin (Cln) function in yeast. Cell 66: 1197-1206.
63. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F, Uchida T, Hunter T, Lu KP. 2002. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci 99: 1335-1340.
64. Liu TH, Li L, Vaessin H. 2002. Transcription of the Drosophila CKI gene dacapo is regulated by a modular array of cis-regulatory sequences. Mech Dev 112: 25-36.
65. Malumbres M, Barbacid M. 2009. Cell cycle, CDKs and cancer: A chang-ing paradigm. Nat Rev Cancer 9: 153-166.
66. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M. 2004. Mammalian cells cycle without the D--type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493-504.
67. Matsushime H, Roussel MF, Ashmum RA, Sherr CJ. 1991. Colony-stim-ulating factor 1 regulates a novel gene (CYL1) during the G1 phase of the cell cycle. Cell 65: 701-713.
68. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 1995. 5 ′ CpG island methylation is associated with tran-scriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692.
69. Meyer CA, Jacobs HW, Datar SA, Du W, Edgar BA, Lehner CF. 2000. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J 19: 4533-4542.
70. Dacapo expression during embryogenesis is con-trolled by a complex regulatory region independent of cell cycle pro-gression. Development 129: 319-328.
71. Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bern-stein ID, Roberts JM, Clurman BE. 2008. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 22: 1677-1689.
72. Morrison DK. 2012. MAP kinase pathways. Cold Spring Harb Perspect Biol 4: 011254.
73. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A. 1991. A novel cyclin encoded by a bcl1-linked candi-date oncogene. Nature 350: 512-515.
74. Nash P, Tang X, Orlicky S, Chen Q, Gertler FB, Mendenhall MD, Sicheri F, Pawson T, Tyers M. 2001. Multisite phosphorylation of a CDK inhib-itor sets a threshold for the onset of DNA replication. Nature 414: 514-521.
75. Nicholson SC, Nicolay BN, Frolov MV, Moberg KH. 2011. Notch-depen-dent expression of the archipelago ubiquitin ligase subunit in the Drosophila eye. Development 138: 251-260.
76. Nishitani H, Shiomi Y, Iida H, Michishita M, Takami T, Tsurimoto T. 2008. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem 283: 29045-29052.
77. Nusse R. 2012. Wnt signaling. Cold Spring Harb Perspect Biol 4: a011163.
78. Ohtani K, Degregori J, Nevins JR. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci 92: 12146-12150.
79. Ohtsubo M, Roberts JM. 1993. Cyclin-dependent regulation of G 1 in mammalian fibroblasts. Science 259: 1908-1912.
80. Ortega S, Malumbres M, Barbacid M. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87.
81. Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M. 2003. Cyclin-dependent kinase 2 is essen-tial for meiosis but not for mitotic cell division in mice. Nat Genet 35: 25-31.
82. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase in-hibitor p27. Science 269: 682-685.
83. Parisi T, Beck AR, Rougier N, McNeil T, Lucian L, Werb Z, Amati B. 2003. Cyclins E1 and E2 are required for endoreplication in placental tro-phoblast giant cells. EMBO J 22: 4794-4803.
84. Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai S-Y, Ho IC, Perou CM, Xiong Y. 2009. CDK inhibitor p18INK4c is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumor-igenesis. Cancer Cell 15: 389-401.
85. Resnitzky D, Gossen M, Bujard H, Reed S. 1994. Acceleration of the G1 /S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679.
86. Rhind N, Russel P. 2012. Signaling pathways that regulate cell division. Cold Spring Harb Perspect Biol 4: a005942.
87. Roussel MF. 1999. The INK4 family of cell cycle inhibitors in cancer. Oncogene 18: 5311-5317.
88. Schneider BL, Yang QH, Futcher AB. 1996. Linkage of replication to start by the Cdk inhibitor Sic1. Science 272: 560-562.
89. SIC1 controls the G 1 to S transition in S. cerevisiae. Cell 79: 233-244.
90. Serrano M, Hannon GJ, Beach D. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
91. Sherr CJ. 1996. Cancer cell cycle. Science 274: 1672-1677.
92. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G 1 cyclin-depen-dent kinases. Genes Dev 9: 1149-1163.
93. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711.
94. Skowyra D, Craig K, Tyers M, Elledge SJ, Harper JW. 1997. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiq-uitin-ligase complex. Cell 91: 209-219.
95. Smith AP, Henze M, Lee JA, Osborn KG, Keck JM, Tedesco D, Bortner DM, Rosenberg MP, Reed SI. 2006. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland. Oncogene 25: 7245-7259.
96. Starostina NG, Kipreos ET. 2012. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol 22: 33-41.
97. Terada Y, Tatsuka M, Jinno S, Okayama H. 1995. Requirement for tyro-sine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet ir-radiation. Nature 376: 358-362.
98. van den Heuvel S, Dyson NJ. 2008. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9: 713-724.
99. m-myc transgenic mice by provirus tagging. Cell 65: 737-752.
100. Wander SA, Zhao D, Slingerland JM. 2011. p27: A barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res 17: 12-18.
101. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgen-ic mice. Nature 369: 669-671.
102. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
103. Welcker M, Clurman BE. 2008. FBW7 ubiquitin ligase: A tumour sup-pressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8: 83-93.
104. Xiong W, Ferrell JE Jr. 2003. A positive-feedback-based bistable "memory module" that governs a cell fate decision. Nature 426: 460-465.
105. Xiong Y, Connolly T, Futcher B, Beach D. 1991. Human D-type cyclin. Cell 65: 691-699.
106. Xiong Y, Zhang H, Beach D. 1992. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514.
107. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D. 1993a. p21 is a universal inhibitor of the cyclin kinases. Nature 366: 701-704.
108. Xiong Y, Zhang H, Beach D. 1993b. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7: 1572-1583.
109. Yu Q, Geng Y, Sicinski P. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411: 1017-1021.
110. INK4C. Nat Cell Biol 6: 436-442.
111. Zhao H, Chen X, Gurian-West M, Roberts JM. 2012. Loss of cyclin-dependent kinase 2 (CDK2) inhibitory phosphorylation in a CDK2AF knock-in mouse causes misregulation of DNA replication and centro-some duplication. Mol Cell Biol 32: 1421-1432.
112. Zindy F, Quelle DE, Roussel MF, Sherr CJ. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15: 203-211.